SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-11-006697
Filing Date
2011-07-28
Accepted
2011-07-28 12:29:46
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a2204894z10-q.htm 10-Q 335456
2 EX-31.1 a2204894zex-31_1.htm EX-31.1 14837
3 EX-32.1 a2204894zex-32_1.htm EX-32.1 7561
10 G384178.JPG g384178.jpg GRAPHIC 10449
  Complete submission text file 0001047469-11-006697.txt   1642005

Data Files

Seq Description Document Type Size
4 EX-101.INS nutr-20110630.xml EX-101.INS 156726
5 EX-101.SCH nutr-20110630.xsd EX-101.SCH 8493
6 EX-101.CAL nutr-20110630_cal.xml EX-101.CAL 37193
7 EX-101.DEF nutr-20110630_def.xml EX-101.DEF 59885
8 EX-101.LAB nutr-20110630_lab.xml EX-101.LAB 166978
9 EX-101.PRE nutr-20110630_pre.xml EX-101.PRE 85471
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 11992597
SIC: 2833 Medicinal Chemicals & Botanical Products